Year |
Citation |
Score |
2023 |
Mohamed H, Berman R, Connors J, Haddad EK, Miller V, Nonnemacher MR, Dampier W, Wigdahl B, Krebs FC. Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy. Biomedicines. 11. PMID 36672628 DOI: 10.3390/biomedicines11010122 |
0.384 |
|
2021 |
Mohamed H, Clemen R, Freund E, Lackmann JW, Wende K, Connors J, Haddad EK, Dampier W, Wigdahl B, Miller V, Bekeschus S, Krebs FC. Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection. Plos One. 16: e0247125. PMID 33647028 DOI: 10.1371/journal.pone.0247125 |
0.422 |
|
2020 |
Mohamed H, Miller V, Jennings SR, Wigdahl B, Krebs FC. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook. Journal of Immunology Research. 2020: 9470102. PMID 32537473 DOI: 10.1155/2020/9470102 |
0.355 |
|
2017 |
Banerjee A, Li L, Pirrone V, Krebs FC, Wigdahl B, Nonnemacher MR. cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells. Clinical Medicine Insights. Pathology. 10: 1179555717694535. PMID 28469516 DOI: 10.1177/1179555717694535 |
0.348 |
|
2016 |
Dampier W, Antell GC, Aiamkitsumrit B, Nonnemacher MR, Jacobson JM, Pirrone V, Zhong W, Kercher K, Passic S, Williams JW, James T, Devlin KN, Giovannetti T, Libon DJ, Szep Z, ... ... Krebs FC, et al. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status. Journal of Neurovirology. PMID 27400931 DOI: 10.1007/S13365-016-0462-3 |
0.367 |
|
2016 |
James T, Nonnemacher MR, Wigdahl B, Krebs FC. Defining the roles for Vpr in HIV-1-associated neuropathogenesis. Journal of Neurovirology. PMID 27056720 DOI: 10.1007/S13365-016-0436-5 |
0.413 |
|
2016 |
Keogan S, Siegert K, Wigdahl B, Krebs FC. Variability in human semen content and its potential effects in the female reproductive tract Journal of Reproductive Biology and Health. 4: 1. DOI: 10.7243/2054-0841-4-1 |
0.691 |
|
2015 |
Keogan S, Siegert K, Wigdahl B, Krebs FC. Critical Review: Immunomodulation by Seminal Factors and Implications for Male-to-Female HIV-1 Transmission. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 131-7. PMID 25642971 DOI: 10.1097/Qai.0000000000000561 |
0.743 |
|
2012 |
Lozenski K, Ownbey R, Wigdahl B, Kish-Catalone T, Krebs FC. Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety. Bmc Pharmacology & Toxicology. 13: 9. PMID 23025553 DOI: 10.1186/2050-6511-13-9 |
0.741 |
|
2012 |
Kortagere S, Madani N, Mankowski MK, Schön A, Zentner I, Swaminathan G, Princiotto A, Anthony K, Oza A, Sierra LJ, Passic SR, Wang X, Jones DM, Stavale E, Krebs FC, et al. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid. Journal of Virology. 86: 8472-81. PMID 22647699 DOI: 10.1128/Jvi.05006-11 |
0.375 |
|
2012 |
Keogan S, Passic S, Krebs FC. Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat. International Journal of Peptides. 2012: 349427. PMID 22319541 DOI: 10.1155/2012/349427 |
0.749 |
|
2012 |
Pirrone V, Passic S, Wigdahl B, Krebs FC. Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1. Virology Journal. 9: 33. PMID 22281044 DOI: 10.1186/1743-422X-9-33 |
0.438 |
|
2012 |
McFadden K, Fletcher P, Rossi F, Kantharaju, Umashankara M, Pirrone V, Rajagopal S, Gopi H, Krebs FC, Martin-Garcia J, Shattock RJ, Chaiken I. Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors. Antimicrobial Agents and Chemotherapy. 56: 1073-80. PMID 22083481 DOI: 10.1128/Aac.05555-11 |
0.428 |
|
2012 |
Hartmann SU, Krebs F, Wigdahl B, Sokal D, Baniecki ML, Owen D, Gerrard S, Kneen E. A Microbicidal Nipple Shield: An Innovative Method for Prevention of Mother-to-Child Transmission Of HIV Through Breastfeeding Gender Medicine. 9: S95. DOI: 10.1016/J.Genm.2011.09.007 |
0.397 |
|
2012 |
Lozenski K, Kish-Catalone T, Wigdahl B, Krebs F. In Vitro and In Vivo Measures of Microbicide Safety Differ Considerably in a Multiple Exposure Study Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.005 |
0.701 |
|
2012 |
Krebs F, Pirrone V, Passic S, Wigdahl B. In Vitro Enhancement of HIV-1 Infection as a Potential Contributor to the Clinical Failures of Select Polyanionic Microbicide Candidates Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.004 |
0.456 |
|
2012 |
Keogan S, Passic S, Wigdahl B, Krebs F. Cationic Cell Penetrating Peptides as Potential Inhibitors of HIV-1 Infection Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.003 |
0.749 |
|
2011 |
Lozenski K, Kish-Catalone T, Pirrone V, Rando RF, Labib M, Wigdahl B, Krebs FC. Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model Journal of Biomedicine and Biotechnology. 2011. PMID 22131821 DOI: 10.1155/2011/941061 |
0.756 |
|
2011 |
Pirrone V, Wigdahl B, Krebs FC. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1. Antiviral Research. 90: 168-82. PMID 21439325 DOI: 10.1016/J.Antiviral.2011.03.176 |
0.398 |
|
2011 |
Pirrone V, Thakkar N, Jacobson JM, Wigdahl B, Krebs FC. Combinatorial approaches to the prevention and treatment of HIV-1 infection. Antimicrobial Agents and Chemotherapy. 55: 1831-42. PMID 21343462 DOI: 10.1128/Aac.00976-10 |
0.401 |
|
2010 |
Passic SR, Ferguson ML, Catalone BJ, Kish-Catalone T, Kholodovych V, Zhu W, Welsh W, Rando R, Howett MK, Wigdahl B, Labib M, Krebs FC. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1 Biomedicine and Pharmacotherapy. 64: 723-732. PMID 21106331 DOI: 10.1016/J.Biopha.2010.10.001 |
0.372 |
|
2010 |
Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL. Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1. Virology. 408: 80-8. PMID 20880566 DOI: 10.1016/J.Virol.2010.09.004 |
0.384 |
|
2010 |
Pirrone V, Passic S, Wigdahl B, Rando RF, Labib M, Krebs FC. A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection. Journal of Biomedicine & Biotechnology. 2010: 548749. PMID 20589074 DOI: 10.1155/2010/548749 |
0.394 |
|
2010 |
Thakkar N, Pirrone V, Passic S, Keogan S, Zhu W, Kholodovych V, Welsh W, Rando R, Labib M, Wigdahl B, Krebs FC. Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 54: 1965-72. PMID 20231400 DOI: 10.1128/Aac.00934-09 |
0.748 |
|
2009 |
Thakkar N, Pirrone V, Passic S, Zhu W, Kholodovych V, Welsh W, Rando RF, Labib ME, Wigdahl B, Krebs FC. Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 53: 631-8. PMID 19047650 DOI: 10.1128/Aac.00866-08 |
0.314 |
|
2009 |
Pirrone V, Passic S, Wigdahl B, Krebs F. Clinical Failures of Select Polyanionic Microbicide Candidates may be Predicted by In Vitro Enhancement of HIV-1 Infection Antiviral Research. 82: A65-A66. DOI: 10.1016/J.Antiviral.2009.02.159 |
0.433 |
|
2009 |
Passic S, Pirrone V, Wigdahl B, Doncel G, Krebs F. Using the Conrad Testing Algorithm to Evaluate the Cytotoxicity and Anti-HIV-1 Activity of Candidate Microbicide Compounds Antiviral Research. 82: A65. DOI: 10.1016/J.Antiviral.2009.02.158 |
0.403 |
|
2009 |
Lozenski K, Kish-Catalone T, Wigdahl B, Krebs F. Nonoxynol-9 (N-9), After Repeated Applications, Does not Result in Cumulative Damage to the Murine Cervicovaginal Epithelium Antiviral Research. 82: A64-A65. DOI: 10.1016/J.Antiviral.2009.02.156 |
0.697 |
|
2009 |
Keogan S, Pirrone V, Passic S, Wigdahl B, Krebs F. Induction of HIV-1 Gene Expression in Human Monocytic Cells by the Failed Microbicide Carrageenan Occurs Through Activation of Toll-like Receptor 4 (TLR4) Antiviral Research. 82: A64. DOI: 10.1016/J.Antiviral.2009.02.154 |
0.733 |
|
2009 |
Thakkar N, Pirrone V, Passic S, Labib M, Rando R, Wigdahl B, Krebs F. Immediate and Persistent Anti-HIV-1 Activity of the Biguanide-based Compound NB325 Involves Specific Interactions with the Viral Co-receptor CXCR4 Antiviral Research. 82: A26. DOI: 10.1016/J.Antiviral.2009.02.041 |
0.428 |
|
2005 |
Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 430-7. PMID 16154721 DOI: 10.1016/J.Biopha.2005.07.008 |
0.398 |
|
2005 |
Krebs FC, Miller SR, Ferguson ML, Labib M, Rando RF, Wigdahl B. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 438-45. PMID 16154720 DOI: 10.1016/J.Biopha.2005.07.007 |
0.424 |
|
2005 |
Kish-Catalone T, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S98. DOI: 10.1186/1742-4690-2-S1-S98 |
0.363 |
|
2005 |
Qian J, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S96. DOI: 10.1186/1742-4690-2-S1-S96 |
0.406 |
|
2005 |
Pirrone V, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S95. DOI: 10.1186/1742-4690-2-S1-S95 |
0.404 |
|
2005 |
Thakkar N, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: P94. DOI: 10.1186/1742-4690-2-S1-P94 |
0.432 |
|
2005 |
Ferguson ML, Miller S, Labib ME, Rando R, Kholodovych V, Welsh W, Wigdahl B, Krebs FC. Retrovirology. 2: P30. DOI: 10.1186/1742-4690-2-S1-P30 |
0.348 |
|
2004 |
Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrobial Agents and Chemotherapy. 48: 1837-47. PMID 15105142 DOI: 10.1128/Aac.48.5.1837-1847.2004 |
0.388 |
|
2004 |
Kensinger RD, Catalone BJ, Krebs FC, Wigdahl B, Schengrund CL. Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 48: 1614-23. PMID 15105112 DOI: 10.1128/Aac.48.5.1614-1623.2004 |
0.404 |
|
2003 |
Quiterio S, Grant C, Hogan TH, Krebs FC, Wigdahl B. C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 57: 49-56. PMID 12642037 DOI: 10.1016/S0753-3322(02)00332-3 |
0.363 |
|
2003 |
Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. Journal of Neurovirology. 9: 55-68. PMID 12587069 DOI: 10.1080/13550280390173292 |
0.301 |
|
2002 |
Hogan TH, Krebs FC, Wigdahl B. Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. Journal of Neurovirology. 8: 21-6. PMID 12491147 DOI: 10.1080/13550280290167911 |
0.352 |
|
2000 |
Krebs FC, Ross H, McAllister J, Wigdahl B. HIV-I-associated central nervous system dysfunction Advances in Pharmacology. 49: 315-385. PMID 11013768 DOI: 10.1016/S1054-3589(00)49031-9 |
0.41 |
|
1999 |
Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate Antiviral Research. 43: 157-173. PMID 10551374 DOI: 10.1016/S0166-3542(99)00044-3 |
0.401 |
|
1994 |
Tillmann M, Krebs FC, Wessner R, Pomeroy SM, Goodenow MM, Wigdahl B. Neuroglial-specific factors and the regulation of retrovirus transcription Advances in Neuroimmunology. 4: 305-318. PMID 7874399 DOI: 10.1016/S0960-5428(06)80271-8 |
0.303 |
|
Show low-probability matches. |